摘要:
This invention provides a fine particle composite comprising fine particles of a sulfide or sulfide complex comprising at least one element selected from the group consisting of molybdenum (Mo), rhodium (Rh), ruthenium (Ru), and rhenium (Re) and conductive fine particles via a step of preparing a solvent mixture from a compound containing conductive carbon powder, at least one compound containing an element selected from among molybdenum (Mo), rhodium (Rh), ruthenium (R), and rhenium (Re), and sulfur (S) and a step of conducting a hydrothermal or solvothermal reaction at a pressure and temperature that convert the solvent mixture into a supercritical or subcritical water or solvent.
摘要:
Disclosed is an exhaust gas purifying catalyst in which grain growth of a noble metal particle supported on a support is suppressed. Also, disclosed is a production process of an exhaust gas purifying catalyst, by which the above exhaust gas purifying catalyst can be produced. The exhaust gas purifying catalyst comprises a crystalline metal oxide support and a noble metal particle supported on the support, wherein the noble metal particle is epitaxially grown on the support, and wherein the noble metal particle is dispersed and supported on the outer and inner surfaces of the support. The process for producing an exhaust gas purifying catalyst comprises masking, in a solution, at least a part of the surface of a crystalline metal oxide support by a masking agent, introducing the support into a noble metal-containing solution containing a noble metal, and drying and firing the support and the noble metal-containing solution to support the noble metal on the support.
摘要:
Disclosed is a novel spicamycin derivative represented by the formula (I) or a salt thereof: ##STR1## wherein R represents an alkenyl having a given number of carbon atoms, a haloalkyl having a given number of carbon atoms, CH.sub.3 (CH.sub.2).sub.n CH(OH)-- or CH.sub.3 (CH.sub.2).sub.n-1 CH(OH)--CH.sub.2 -- (wherein n denotes an integer of 9-13), an alkyl with a certain group and a given number of carbon atoms, ##STR2## (wherein a denotes 2, and b denotes an integer of 10-15), CH.sub.3 (CH.sub.2).sub.c SO.sub.2 O(CH.sub.2).sub.d --, ##STR3## (wherein c denotes an integer of 0-3 and d denotes an integer of 10-15), (CH.sub.3).sub.3 Si(CH.sub.2).sub.10 --,(CH.sub.3).sub.3 Si--C.tbd.C--(CH.sub.2).sub.8 --, ##STR4## (wherein X represents O or S), and R.sub.1 and R.sub.2 are different from each other and each represents H or OH, which exhibits an excellent antitumor effect and has a high therapeutic index.An antitumor agent containing at least one of the above-described compounds in an effective amount is also disclosed.
摘要:
Spicamycin derivative represented by the formula (I) or a salt thereof: ##STR1## wherein R represents specific diverse substituents, for example, a linear alkadienyl having from 11 to 13 carbon atoms, and R.sub.1 and R.sub.2 respectively represent H or OH. Examples of specific compounds are 6-[4'-N-(N'-trans,trans 2,4-tridecadienoylglycyl)spicaminyl-amino]purine, and 6-[4'-N-(N'-trans,trans-2,4 dodecadienyoly glycyl) spicaminyl-amino]purine. Comopunds according to this invention are useful as a pharmaceutical for inhibition of a tumor, for example, human colon cancer.
摘要:
Disclosed is a novel anthracycline compound of the following formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are each a hydroxyl group or a hydrogen atom and satisfy the condition that, when R.sup.2 is a hydroxyl group, R.sup.1 is a hydroxyl group or a hydrogen atom, whereas, when R.sup.2 is a hydrogen atom, R.sup.1 is a hydrogen atom, or an acid addition salt thereof.These compounds can be contained as active ingredients in antitumor agents, whereby good results are attainable.